AVE Receipt of R&D Tax Incentive 13/06/24 PRICE SENSITIVE download Created with Sketch. 98.44KB Share AVE 2024 Annual General Meeting Results 30/05/24 download Created with Sketch. 90.97KB Share AVE Chair's Address and CEO Presentation 30/05/24 PRICE SENSITIVE download Created with Sketch. 1.71MB Share AVE Notification of cessation of securities - AVE 21/05/24 download Created with Sketch. 12.84KB Share AVE First Patient dosed in Phase III insomnia trial 16/05/24 PRICE SENSITIVE download Created with Sketch. 85.94KB Share AVE March 2024 Quarterly Activities Report & Appendix 4C 30/04/24 PRICE SENSITIVE download Created with Sketch. 318.85KB Share AVE Initial Director's Interest Notice 26/04/24 download Created with Sketch. 204.79KB Share AVE Notice of Annual General Meeting/Proxy Form 26/04/24 download Created with Sketch. 414.48KB Share AVE Notification regarding unquoted securities - AVE 26/04/24 download Created with Sketch. 15.95KB Share AVE Appointment of New Director 26/04/24 download Created with Sketch. 73.35KB Share AVE Monash Sleep Health Symposium 22/04/24 download Created with Sketch. 104.19KB Share AVE Avecho commences Phase III insomnia trial 26/03/24 PRICE SENSITIVE download Created with Sketch. 202.98KB Share AVE Avecho to present at NWR Virtual Healthcare Conference 18/03/24 download Created with Sketch. 87.99KB Share AVE Avecho meets TGA ahead of Phase III Clinical Trial 14/03/24 PRICE SENSITIVE download Created with Sketch. 67.34KB Share AVE AVE receives final ethics approval for Phase III CBD trial 07/03/24 PRICE SENSITIVE download Created with Sketch. 74.51KB Share AVE Appendix 4G and Corporate Governance Statement 29/02/24 download Created with Sketch. 574KB Share AVE Appendix 4E and Annual Report 31 December 2023 29/02/24 PRICE SENSITIVE download Created with Sketch. 1.4MB Share AVE December 2023 Quarterly Activities Report & Appendix 4C 31/01/24 PRICE SENSITIVE download Created with Sketch. 299.59KB Share AVE Expiry of Quoted Options 28/11/23 download Created with Sketch. 241.34KB Share AVE Change of Director's Interest Notice x2 23/11/23 download Created with Sketch. 390.32KB Share AVE Application for quotation of securities - AVE 22/11/23 download Created with Sketch. 30.11KB Share AVE 2023 General Meeting Results 09/11/23 download Created with Sketch. 473.79KB Share AVE CEO Presentation 09/11/23 download Created with Sketch. 19.94MB Share AVE September 2023 Quarterly Activities Report & Appendix 4C 31/10/23 PRICE SENSITIVE download Created with Sketch. 495.04KB Share AVE Investor Presentation 13/10/23 download Created with Sketch. 1.2MB Share AVE Phase III Clinical Trial Investor Webinar 11/10/23 download Created with Sketch. 57.35KB Share AVE Notice of General Meeting/Proxy Form 09/10/23 download Created with Sketch. 856.3KB Share AVE Application for quotation of securities - AVE 07/09/23 download Created with Sketch. 23.2KB Share AVE Appendix 4D and Half-year Financial Report 31/08/23 PRICE SENSITIVE download Created with Sketch. 1.37MB Share AVE Reinstatement to Official Quotation 28/08/23 PRICE SENSITIVE download Created with Sketch. 86.84KB Share AVE Proposed issue of securities - AVE 28/08/23 download Created with Sketch. 29.46KB Share AVE Proposed issue of securities - AVE 28/08/23 download Created with Sketch. 27.65KB Share AVE Avecho raises further $6M for Phase III trial 28/08/23 PRICE SENSITIVE download Created with Sketch. 91.03KB Share AVE Voluntary Suspension 25/08/23 PRICE SENSITIVE download Created with Sketch. 168.59KB Share AVE Trading Halt 23/08/23 PRICE SENSITIVE download Created with Sketch. 142.38KB Share AVE June 2023 Quarterly Activities Report & Appendix 4C 25/07/23 PRICE SENSITIVE download Created with Sketch. 268.38KB Share AVE Update - Application for quotation of securities - AVE 28/06/23 download Created with Sketch. 24.22KB Share AVE Application for quotation of securities - AVE 28/06/23 download Created with Sketch. 24.72KB Share AVE AVE CBD capsule passes two-year stability milestone 22/06/23 PRICE SENSITIVE download Created with Sketch. 82.85KB Share AVE AVE adds TPM cannabinoid gummies to portfolio 07/06/23 PRICE SENSITIVE download Created with Sketch. 86.38KB Share AVE USPTO allows new TPM manufacturing patent 29/05/23 PRICE SENSITIVE download Created with Sketch. 79.48KB Share AVE 2023 Annual General Meeting Results 23/05/23 download Created with Sketch. 80.21KB Share AVE Chair's Address and CEO Presentation 23/05/23 download Created with Sketch. 1.53MB Share AVE Avecho licenses TPM for use in cancer drugs 22/05/23 PRICE SENSITIVE download Created with Sketch. 116.81KB Share AVE Withdrawal of AGM Resolutions 5(c) and 5(d) 18/05/23 download Created with Sketch. 202.07KB Share AVE AVE commences manufacturing for Phase III trial 17/05/23 PRICE SENSITIVE download Created with Sketch. 283.12KB Share AVE Change in Substantial Holding 16/05/23 download Created with Sketch. 421.52KB Share AVE Change of Director's Interest Notice x2 10/05/23 download Created with Sketch. 447.29KB Share AVE Top 20 Option Holders 10/05/23 download Created with Sketch. 31.95KB Share AVE Application for quotation of securities - AVE 10/05/23 download Created with Sketch. 27.01KB Share AVE Results of Entitlement Offer 09/05/23 PRICE SENSITIVE download Created with Sketch. 132.8KB Share AVE Receipt of R&D Tax Incentive 02/05/23 PRICE SENSITIVE download Created with Sketch. 201.89KB Share AVE March 2023 Quarterly Activities Report & Appendix 4C 28/04/23 PRICE SENSITIVE download Created with Sketch. 363.87KB Share AVE Notice of Annual General Meeting/Proxy Form 21/04/23 download Created with Sketch. 538.62KB Share AVE Notice to Ineligible Foreign Shareholders 13/04/23 download Created with Sketch. 112.82KB Share AVE Notice to Eligible Shareholders 13/04/23 download Created with Sketch. 133.79KB Share AVE Letter to Optionholders 03/04/23 download Created with Sketch. 49.78KB Share AVE Target Market Determination 03/04/23 download Created with Sketch. 145.57KB Share AVE Proposed issue of securities - AVE 03/04/23 download Created with Sketch. 46.03KB Share AVE Investor Presentation 03/04/23 PRICE SENSITIVE download Created with Sketch. 1.68MB Share AVE Prospectus 03/04/23 PRICE SENSITIVE download Created with Sketch. 624.94KB Share AVE Entitlement Offer to raise $11m for Phase 3 clinical trial 03/04/23 PRICE SENSITIVE download Created with Sketch. 196.62KB Share AVE Avecho to present at NWR Virtual Healthcare Conference 17/03/23 download Created with Sketch. 61.68KB Share AVE Appendix 4G and Corporate Governance Statement 15/03/23 download Created with Sketch. 482.77KB Share AVE Annual Report - 31 December 2022 15/03/23 download Created with Sketch. 1.3MB Share AVE Appendix 4E - Preliminary Final Report 28/02/23 PRICE SENSITIVE download Created with Sketch. 182.16KB Share AVE Clinical CBD program expands with the Lambert Initiative 22/02/23 PRICE SENSITIVE download Created with Sketch. 78.69KB Share AVE December 2022 Quarterly Activities Report & Appendix 4C 31/01/23 PRICE SENSITIVE download Created with Sketch. 273.71KB Share AVE Athenex submits Avecho's phytonadione to FDA pre-IND 12/01/23 PRICE SENSITIVE download Created with Sketch. 238.19KB Share AVE Avecho receives ethics approval for Phase III CBD trial 22/12/22 PRICE SENSITIVE download Created with Sketch. 131.46KB Share AVE AVE signs development agreement with Perrigo 20/12/22 PRICE SENSITIVE download Created with Sketch. 269.72KB Share AVE September 2022 Quarterly Activities Report & Appendix 4C 28/10/22 PRICE SENSITIVE download Created with Sketch. 310.85KB Share AVE Increased CBD absorption in dogs vs commercial comparator 19/09/22 PRICE SENSITIVE download Created with Sketch. 85.86KB Share AVE Application for quotation of securities - AVE 01/09/22 download Created with Sketch. 24.69KB Share AVE Section 708A Cleansing Statement 01/09/22 download Created with Sketch. 92.39KB Share AVE Appendix 4D and Half-year Financial Report 29/08/22 PRICE SENSITIVE download Created with Sketch. 598.88KB Share AVE June 2022 Quarterly Activities Report & Appendix 4C 29/07/22 PRICE SENSITIVE download Created with Sketch. 176.18KB Share AVE Security Class Reinstatement to Quotation- AVEO 14/07/22 PRICE SENSITIVE download Created with Sketch. 86.31KB Share AVE Update on Listed Options and Federal Court Application 14/07/22 PRICE SENSITIVE download Created with Sketch. 239.84KB Share AVE Suspension from Official Quotation - AVEO 08/06/22 PRICE SENSITIVE download Created with Sketch. 148.32KB Share AVE Adoption of New Constitution 30/05/22 download Created with Sketch. 1.24MB Share AVE 2022 Annual General Meeting Results 30/05/22 download Created with Sketch. 358.14KB Share AVE Chair's Address and CEO Presentation 30/05/22 download Created with Sketch. 1.64MB Share AVE Receipt of R&D Tax Incentive 03/05/22 PRICE SENSITIVE download Created with Sketch. 92.21KB Share AVE March 2022 Quarterly Activities Report & Appendix 4C 29/04/22 PRICE SENSITIVE download Created with Sketch. 142.17KB Share AVE Notice of Annual General Meeting/Proxy Form 28/04/22 download Created with Sketch. 509.41KB Share AVE Positive results from AVE's topical CBD pain study 29/03/22 PRICE SENSITIVE download Created with Sketch. 274.68KB Share AVE Dosing begins in topical CBD pain study 01/03/22 PRICE SENSITIVE download Created with Sketch. 93.08KB Share AVE Appendix 4G and Corporate Governance Statement 28/02/22 download Created with Sketch. 565.04KB Share AVE Appendix 4E and Annual Report 31 December 2021 28/02/22 PRICE SENSITIVE download Created with Sketch. 1.38MB Share AVE AVE license agreement for US recreational cannabis market 02/02/22 PRICE SENSITIVE download Created with Sketch. 203.08KB Share AVE December 2021 Quarterly Activities Report & Appendix 4C 31/01/22 PRICE SENSITIVE download Created with Sketch. 294.5KB Share AVE Application for quotation of securities - AVE 10/01/22 download Created with Sketch. 27.42KB Share AVE Section 708A Cleansing Statement 10/01/22 download Created with Sketch. 171.34KB Share AVE AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis 20/12/21 PRICE SENSITIVE download Created with Sketch. 214.39KB Share AVE Positive results from Avecho's Phase I trial of CBD soft-gel 08/12/21 PRICE SENSITIVE download Created with Sketch. 122.89KB Share AVE September 2021 Quarterly Activities Report & Appendix 4C 29/10/21 PRICE SENSITIVE download Created with Sketch. 754.33KB Share AVE Topical CBD pain study with Lambert Initiative approved 21/10/21 PRICE SENSITIVE download Created with Sketch. 151.27KB Share AVE Dosing begins in Phase I PK trial testing CBD soft-gel 04/10/21 PRICE SENSITIVE download Created with Sketch. 92.31KB Share AVE Phase I clinical trial testing CBD product-enrolment begins 15/09/21 PRICE SENSITIVE download Created with Sketch. 72.69KB Share